Business · 16/05/2018
FDA Announces Upcoming Blood Products Advisory Committee Meeting
The Food and Drug Administration (FDA) is hosting a public meeting of the Blood Products Advisory Committee to discuss bacterial risk control strategies for platelet transfusions and classify medical devices. The meeting will be open to the public and will take place on an upcoming date.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →